Three-dimensional imaging in central serous chorioretinopathy

被引:0
|
作者
Stock, G. [1 ]
Ahlers, C. [1 ]
Sayegh, R. [1 ]
Ritter, M. [1 ]
Kolar, S. [1 ]
Golbaz, I. [1 ]
Schmidt-Erfurth, U. [1 ]
机构
[1] Med Univ Wien, Klin Augenheilkunde & Optometrie, A-1090 Vienna, Austria
来源
OPHTHALMOLOGE | 2008年 / 105卷 / 12期
关键词
High resolution optical coherence tomography; Acute central serous chorioretinopathy; Three-dimensional imaging; Optical coherence tomography;
D O I
10.1007/s00347-008-1741-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background. Conventional optical coherence tomography (OCT) has brought new insights to retinal diagnostics, but it is restricted due to its low scanning speed and limited resolution. In this study, high-resolution raster scanning OCT (HR-OCT) was used to identify typical changes in central serous chorioretinopathy (CSC). Methods. Fifteen consecutive patients with acute CSC were imaged using HR-OCT with an axial image resolution of 6 mu m. The scanned area measured 6x6 mm(2). Three-dimensional (3D) evaluation was performed using various analysing programmes. Results. Topographic changes in CSC could be visualised with 3D reconstructions in all locations. Retinal thickness was measured with the automatic segmentation mode and quantified precisely. Results were presented in 2D and 3D maps. En-face imaging as a modality to present an integrative overview showed specific alterations in CSC. Conclusion. HR-OCT was able to provide essential additional information about CSC when combined with appropriate analysing programmes, allowing the identification of typical differences. Aside from precise volumetric measurements, exact localisation of pathological deviations could be achieved.
引用
收藏
页码:1127 / 1134
页数:8
相关论文
共 50 条
  • [41] Central serous chorioretinopathy: a review of epidemiology and pathophysiology
    Liew, Gerald
    Quin, Godfrey
    Gillies, Mark
    Fraser-Bell, Samantha
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (02) : 201 - 214
  • [42] Transpupillary thermotherapy for chronic central serous chorioretinopathy
    Nazimul Hussain
    Rohit Khanna
    Anjli Hussain
    Taraprasad Das
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244 : 1045 - 1051
  • [43] Choroidal vessel diameter in central serous chorioretinopathy
    Yang, Lihong
    Jonas, Jost B.
    Wei, Wenbin
    ACTA OPHTHALMOLOGICA, 2013, 91 (05) : E358 - E362
  • [44] ORAL MIFEPRISTONE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Nielsen, Jared S.
    Jampol, M.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (09): : 1928 - 1936
  • [45] Retinal Vascular Reactivity in Central Serous Chorioretinopathy
    Piccolino, Felice Cardillo
    Lupidi, Marco
    Cagini, Carlo
    Fruttini, Daniela
    Nicolo, Massimo
    Eandi, Chiara Maria
    Tito, Silvia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (11) : 4425 - 4433
  • [46] Central serous chorioretinopathy: an update on pathogenesis and treatment
    Gemenetzi, M.
    De Salvo, G.
    Lotery, A. J.
    EYE, 2010, 24 (12) : 1743 - 1756
  • [47] Biometric Characteristics of Eyes With Central Serous Chorioretinopathy
    Oh, Jong-Hyun
    Oh, Jaeryung
    Togloom, Ariunaa
    Kim, Seong-Woo
    Huh, Kuhl
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (03) : 1502 - 1508
  • [48] Photodynamic therapy for chronic central serous chorioretinopathy
    Ruiz-Moreno, Jose M.
    Lugo, Francisco L.
    Armada, Felix
    Silva, Rufino
    Montero, Javier A.
    Fernando Arevalo, J.
    Arias, Luis
    Gomez-Ulla, Francisco
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 371 - 376
  • [49] Therapy options for chronic central serous chorioretinopathy
    Maier, M.
    Valet, V.
    Feucht, N.
    Lohmann, C. P.
    OPHTHALMOLOGE, 2011, 108 (11): : 1027 - 1031
  • [50] Retinal microvasculature alteration in central serous chorioretinopathy
    Yu, Li
    Shao, Yi
    Chai, Yong
    Ye, Lin-Hong
    Yang, Qi-Chen
    Ye, Lei
    Yuan, Qing
    Jiang, Nan
    Yi, Jing-Lin
    MOLECULAR MEDICINE REPORTS, 2018, 17 (02) : 2335 - 2340